There are more than 290,000 people estimated to be living in the United States with a spinal cord injury. Previously, it has been shown that it is possible to restore some function to young and healthy patients within a few years of injury. Now, researchers show spinal cord stimulation can immediately restore some voluntary movement and autonomic functions such as cardiovascular, bowel, and bladder years after a paralyzing injury without any significant rehabilitation.
“This was an opportunity to use epidural stimulation, combine my background in mathematics, collaborate with people from multiple disciplines including biomedical engineering and set up a truly innovative trial,” said Dr. David Darrow, a neurosurgery resident at the University of Minnesota Medical School and a lead investigator for the E-STAND Clinical trial. He is also a senior neurosurgery resident at Hennepin Healthcare and University of Minnesota Medical Center. “We wanted to push the envelope for patients. Once we determined it worked, we moved on to knocking down other barriers to translation to patient care.”
In a study recently published in the Journal of Neurotrauma, Darrow and his colleagues implanted the first series of female patients who both suffered devastating traumatic spinal cord injury. Both patients had no lower body function whatsoever and MRIs showing very little residual spinal cord at the level of injury. The two women were five and ten years from injury and in their 5th and 6th decade of life, which is much closer to the average patient with spinal cord injury compared to the work of other investigators.
“Enabling someone to move her legs more than 10 years after being paralyzed from spinal cord injury has been one of the greatest moments of my career,” said Uzma Samadani, MD, PhD, Associate Professor in the Department of Neurosurgery University of Minnesota Medical School and Neurosurgeon with Hennepin Healthcare. “I am grateful to my colleagues for their mutual hard work during the 2 years it took to get from idea to the first operation.”
In this study, researchers expanded the inclusion guidelines of who could receive epidural stimulation.
“We believe that we are studying a population that is much closer to the general population of patients with spinal cord injury,” said Darrow. “We have opened the doors to so many more patients with traumatic spinal cord injury.”
“While we are excited for all this could mean for patients, there is still a lot of research to be done, both with this therapy and through other avenues, many of which we are studying at the University of Minnesota,” said Ann M. Parr, MD, PhD, Assistant Professor in the Department of Neurosurgery at the University of Minnesota Medical School. Dr. Parr has an active translational spinal cord injury research laboratory at the Stem Cell Institute.
This work was made possible by a grant through the Minnesota Office of Higher Education SCI/TBI Grant Program and collaboration of an interdisciplinary group spread across four institutions. The stimulation devices were a gift from Abbott (formerly St. Jude’s).
The Latest on: Spinal cord stimulation
via Google News
The Latest on: Spinal cord stimulation
- Global Spinal Cord Stimulation Devices Market 2020 Industry Research, Business Growth, Future Investment and Emerging Trend to 2025on March 4, 2021 at 8:11 am
MarketsandResearch.biz has added a new key research report entitled Global Spinal Cord Stimulation Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2026 that covers the ...
- Muscle Stimulator Market | Latest Trends and Opportunities Study Analysis Reporton March 2, 2021 at 9:07 pm
The global muscle stimulation devices market is slated to grow passively, at a 3.9% CAGR during 2018-2028. Rising incidences of spinal cord and head injuries is likely to boost growth of the global ...
- Neurog2 directly converts astrocytes into functional neurons in midbrain and spinal cordon March 1, 2021 at 8:53 am
Conversion of astrocytes into neurons in vivo offers an alternative therapeutic approach for neuronal loss after injury or disease. However, not only the efficiency of the conversion of astrocytes ...
- Global Spinal Cord Stimulator (SCS) Device Market 2020 Report Presents Complete Summary, Marketplace Shares and Growth Opportunities by 2025on February 27, 2021 at 11:21 pm
Global Spinal Cord Stimulator (SCS) Device Market 2020 by Manufacturers, Type and Application, Forecast to 2025 ...
- Toll-like receptor-9 stimulated plasmacytoid dendritic cell precursors suppress autoimmune neuroinflammation in a murine model of multiple sclerosison February 26, 2021 at 3:07 am
We herein demonstrate that in vivo or in vitro activation within the BM via Toll-like receptor-9 generates a population of plasmacytoid dendritic cell (pDC) precursors (CpG-pre-pDCs) that, unlike pDC ...
- Nevro posts Street-beating Q4 resultson February 25, 2021 at 8:21 am
Nevro posted Q4 results that beat the consensus forecast on Wall Street as it issued 2021 guidance that was slightly below expectations.
- Nevro Lobs New Suit At Boston Scientific Over Spine Pain IPon February 24, 2021 at 5:45 pm
Nevro Corp., the maker of a spinal cord stimulation technology to treat chronic pain, has lodged a new infringement suit against rival Boston Scientific Corp. for allegedly infringing four of its ...
- Recap: Nevro Q4 Earningson February 24, 2021 at 2:01 pm
Shares of Nevro (NYSE:NVRO) moved lower in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 52.27% year over year ...
- Celéri Health Announces Enrollment of First Patient in Study of Real World Outcomes® for ...on February 23, 2021 at 5:02 am
Celéri Health, a leader in using Real World Outcomes® to change the paradigm of care for people living with chronic pain, today announced the first patient has been enrolled in the UPGRADE Study, ...
- At 12.59% CAGR, Neurostimulation Devices Market Size Set to Register 14.34 Billion USD by 2027on February 23, 2021 at 1:17 am
Brandessence Market Research and Consulting Pvt ltd –:Neurostimulation Devices Market is valued at USD 6.25 Billion in 2020 and expected to reach USD 14.34 Billion by 2027 with a CAGR of 12.59% over ...
via Bing News